Copyright
©The Author(s) 2020.
World J Pharmacol. Oct 28, 2020; 9(1): 1-12
Published online Oct 28, 2020. doi: 10.5497/wjp.v9.i1.1
Published online Oct 28, 2020. doi: 10.5497/wjp.v9.i1.1
Table 1 Clinical research network non-alcoholic fatty liver disease activity score
| Score | Steatosis (%) | Lobular inflammation | Ballooning degeneration |
| 0 | < 5 | None | None |
| 1 | 5 to 33 | < 2 foci | Few |
| 2 | 33 to 66 | 2 to 4 foci | Many |
| 3 | > 66 | > 4 foci |
- Citation: Mukherjee S. Advances in the treatment of nonalcoholic steatohepatitis. World J Pharmacol 2020; 9(1): 1-12
- URL: https://www.wjgnet.com/2220-3192/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.5497/wjp.v9.i1.1